Clover Health Investments, Corp. (CLOV) — Financial statements
Income statement, balance sheet, and cash flow for Clover Health Investments, Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,924↑40.3% | 1,371↑8.8% | 1,261↑15.0% | 1,097↓25.5% | 1,472 | |
| Cost of Revenue | 1,568↑55.9% | 1,006↑0.2% | 1,005↑1.2% | 993↓36.0% | 1,551 | |
| Gross Profit | 356↓2.4% | 365↑42.5% | 256↑147.3% | 103↑230.7% | -79 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 176↓56.9% | 409↓7.1% | 440↓8.7% | 482↑8.2% | 446 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 176↓56.9% | 409↓7.1% | 440↓8.7% | 482↑8.2% | 446 | |
| Other Expenses | 265↑16274.7% | 2↓92.3% | 21↑122.8% | -92↓182.3% | 112 | |
| Operating Expenses | 441↑7.5% | 411↓11.0% | 461↑18.2% | 390↓30.1% | 558 | |
| Total Costs & Expenses | 2,010↑41.8% | 1,417↓3.3% | 1,466↑6.0% | 1,383↓34.4% | 2,109 | |
| Operating Results | ||||||
| Operating Income | -86↓87.0% | -46↑77.7% | -205↑28.4% | -287↑55.0% | -637 | |
| Depreciation & Amortization | 2↑26.7% | 1↓47.0% | 3↑111.4% | 1↓4.7% | 1 | |
| EBITDA | -84↓86.6% | -45↑78.4% | -208↑17.6% | -252↑55.8% | -570 | |
| EBIT | -86↓84.9% | -46↑78.0% | -210↑17.0% | -253↑55.6% | -571 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00↑100.0% | -0.01↑99.5% | -1↑91.9% | -17 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 0.01↓99.5% | 1↓91.9% | 17 | |
| Non-Operating Income | 0.02↓96.1% | 0.52↓89.3% | 5↑114.4% | -33↑49.4% | -66 | |
| Other Income / Expenses | -0.02↑96.1% | -0.52↑89.3% | -5↓115.0% | 32↓34.8% | 49 | |
| Income Before Tax | -86↓84.9% | -46↑78.0% | -210↑17.5% | -255↑56.7% | -588 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -86↓84.9% | -46↑78.0% | -210↑17.5% | -255↑56.7% | -588 | |
| Net Income from Discontinued Operations | 0.00↓100.0% | 3↑201.4% | -3↑96.2% | -85 | 0.00 | |
| Net Income | -86↓98.9% | -43↑79.8% | -213↑37.2% | -340↑42.2% | -588 | |
| Bottom-Line Net Income | -86↓98.9% | -43↑79.8% | -213↑37.2% | -340↑42.2% | -588 | |
| EPS (Basic) | -0.17↓93.6% | -0.09↑80.5% | -0.45↑36.6% | -0.71↑43.2% | -1.25 | |
| EPS (Diluted) | -0.17↓93.6% | -0.09↑80.5% | -0.45↑36.6% | -0.71↑43.2% | -1.25 | |
| Weighted Average Shares | 517↑5.6% | 490↑1.6% | 482↑1.2% | 476↑1.1% | 471 | |
| Weighted Average Diluted Shares | 517↑5.6% | 490↑1.6% | 482↑1.2% | 476↑1.1% | 471 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.